Cargando…
The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells
Vasculogenic mimicry (VM), a process in which aggressive cancer cells form tube-like structures, plays a crucial role in providing nutrients and escape routes. Highly plastic tumor cells, such as those with the triple-negative breast cancer (TNBC) phenotype, can develop VM. However, little is known...
Autores principales: | Morales-Guadarrama, Gabriela, Méndez-Pérez, Edgar A., García-Quiroz, Janice, Avila, Euclides, Ibarra-Sánchez, María J., Esparza-López, José, García-Becerra, Rocío, Larrea, Fernando, Díaz, Lorenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531243/ https://www.ncbi.nlm.nih.gov/pubmed/37762073 http://dx.doi.org/10.3390/ijms241813770 |
Ejemplares similares
-
Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2021) -
Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2022) -
The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
por: Na, Yu Ran, et al.
Publicado: (2021) -
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
por: Coombes, R. C., et al.
Publicado: (2022) -
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
por: Coombes, R. C., et al.
Publicado: (2023)